<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01510522</url>
  </required_header>
  <id_info>
    <org_study_id>EMR200084-508</org_study_id>
    <secondary_id>2011-002508-34</secondary_id>
    <nct_id>NCT01510522</nct_id>
  </id_info>
  <brief_title>Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients Previously Treated With Metformin Tablets</brief_title>
  <official_title>Evaluate Adherence to Treatment With Glucophage Sachets Versus Tablets in Diabetes Type 2 Patients, Previously Treated With Metformin Tablets</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Merck KGaA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck, S.L., Spain</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Merck KGaA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open-label, multicenter, two-arm, parallel, randomized phase 4 study to compare
      the compliance in diabetes type 2 patients treated with Glucophage sachets versus patients
      treated with Glucophage tablets.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>June 2012</start_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline of Patient self-reported subjective compliance as assessed by Haynes-Sackett test at Month 6</measure>
    <time_frame>Month 6</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Objective compliance to treatment</measure>
    <time_frame>Month 3 and month 6</time_frame>
    <description>Objective compliance to treatment is assessed by the accountability of medication returned. Patient is assessed as compliant with an adherence of over 80%.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of treatment satisfaction and preferences with the Diabetes Treatment Satisfaction Questionnaire (DTSQ)</measure>
    <time_frame>Baseline, month 3 and month 6</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of reported adverse events</measure>
    <time_frame>Month 3 and month 6</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Diabetes Mellitus Type 2</condition>
  <arm_group>
    <arm_group_label>Glucophage sachets</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive Glucophage sachets, the powder formulation for oral solution in sachets.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glucophage tablets</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received Glucophage tablets.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucophage</intervention_name>
    <description>Glucophage Powder for oral solution in sachets (metformin hydrochloride in 850mg strengths) Dosing schedule: &gt; 1.700mg/day for 6 month</description>
    <arm_group_label>Glucophage sachets</arm_group_label>
    <other_name>Metformin hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Glucophage</intervention_name>
    <description>Glucophage tablets (metformin hydrochloride in 850mg strengths)
Dosing schedule: &gt; 1.700mg/day for 6 month</description>
    <arm_group_label>Glucophage tablets</arm_group_label>
    <other_name>Metformin hydrochloride</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diabetes mellitus type 2 diagnosed (Baseline Glycemia &gt; 7,0 mmol/L (126 mg/dL) or
             overload Glycemia &gt; 11,0 mmol/L (198 mg/dL)

          -  On treatment with metformin tablets

          -  Patients with at least 2 treated co-morbidities

          -  Established dose of Metformin &gt; 1.700 mg/day

          -  Age &gt; 18 years old

          -  Given informed consent

        Exclusion Criteria:

          -  Patients not able to take medication orally

          -  According to Summary of Product Characteristics (SmPC)

          -  Participating in another clinical trial 30 days prior to randomization

          -  Any other illness or medical or psychiatric condition, severe and uncontrolled that
             could interfere in the patient's participation or in the assessment of the study
             results
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Medical Responsible</last_name>
    <role>Study Director</role>
    <affiliation>Merck, S.L., Spain</affiliation>
  </overall_official>
  <removed_countries>
    <country>Spain</country>
  </removed_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2011</study_first_submitted>
  <study_first_submitted_qc>January 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2012</study_first_posted>
  <last_update_submitted>February 3, 2014</last_update_submitted>
  <last_update_submitted_qc>February 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Glucophage</keyword>
  <keyword>Metformin</keyword>
  <keyword>sachets</keyword>
  <keyword>tablets</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metformin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

